{
    "nctId": "NCT05036083",
    "briefTitle": "Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion",
    "officialTitle": "Added Value of Contrast Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion to a Tertiary Cancer Center",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma, Invasive Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 89,
    "primaryOutcomeMeasure": "Accuracy of contrast enhanced mammography (CEM) for incremental cancer detection in the ipsilateral and contralateral breasts",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients 18 years of age or older with known invasive or in-situ breast cancer (BC) diagnosed at an outside facility and presenting to MD Anderson for staging with imaging\n* Female patients 18 years of age or older referred from outside institutions with imaging findings categorized as highly suspicious (Breast Imaging Reporting and Data System \\[BI-RADS\\] 5 or 4C) on outside imaging or on rereview by MD Anderson's radiologists and referred for staging at MD Anderson Cancer Center (MDACC)\n* Willingness to participate in the study and ability to provide informed consent\n\nExclusion Criteria:\n\n* Breast surgery within 6 months\n* Known allergy to iodine-containing contrast agents\n* History of anaphylactic reaction to any substance that required hospitalization or IV placement\n* Renal insufficiency; hyperthyroidism\n* Detection of non-breast primary or metastatic cancer in the breast",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}